ANDA 85866, held by Lannett. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 85866 (Sodium Butabarbital), held by Lannett, was first approved by FDA on Jul 20, 1978, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 20, 1978 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sodium Butabarbital30MG · tablet;oral | Butabarbital Sodium | Discontinued |
| Feb 6, 2019 | Supplement 7Labeling · Standard review | Approved | None posted |
| Jul 20, 1978 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters